Therapeutic Effect of Ilex hainanensis Merr. Extract on Essential Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open Access
- 8 May 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 9, 424
Abstract
With a rapidly aging population, the prevalence of hypertension in adults continues to rise, placing a substantial and escalating social and economic burden. Ilex hainanensis Merr. is commonly used as a folk remedy for treating hypertension, dyslipidemia and inflammation in China. This systematic review aims to evaluate current evidence for the therapeutic effect of Ilex hainanensis Merr. extract (EIH) on essential hypertension. Six electronic databases (Pubmed, MEDLINE, The Cochrane Central Register of Controlled Trials, Chinese Scientific Journals Database, Wanfang and CNKI) were searched to identify eligible randomized controlled trials (RCTs) relevant to EIH on essential hypertension up to Jan 2018. Six RCTs including 772 participants met eligibility criteria. Methodological quality of the trials was generally low. Meta-analysis showed that EIH demonstrated a beneficial effect for lowering systolic and diastolic blood pressure (SBP/DBP), left ventricular mass (LVM) in participants with essential hypertension. There was no significant difference between EIH and antihypertensive drugs in SBP (WMD: -0.44 [-2.30, 1.43]; P =0.65), DBP (WMD: WMD: -0.02[-1.13, 1.09]; P =0.98) and LVM (WMD: -1.36 [-4.99, 2.26]; P =0.46). Moreover, one trial showed that EIH combined with antihypertensive drugs was more effective in lowering blood pressure than those antihypertensive drugs used alone. However, the findings were limited by the small sample sizes, duration and low methodological quality of the trials. This is the first systematic review of EIH on essential hypertension. More rigorous RCTs with high quality are still needed to prove the effectiveness and safety of EIH and its preparations for essential hypertension.Keywords
Funding Information
- National Natural Science Foundation of China (81603479)
This publication has 35 references indexed in Scilit:
- Chinese Herbal Medicine Qi Ju Di Huang Wan for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled TrialsEvidence-Based Complementary and Alternative Medicine, 2013
- Prevalence, awareness, treatment and control of hypertension in elderly ChineseHypertension Research, 2013
- Erratum: Proposal of new strategy for ambulatory blood pressure profile-based management of resistant hypertension in the era of renal denervationHypertension Research, 2013
- Proposal of a new strategy for ambulatory blood pressure profile-based management of resistant hypertension in the era of renal denervationHypertension Research, 2013
- Use of Herbal Products and Potential Interactions in Patients With Cardiovascular DiseasesJACC, 2010
- Complete assignments of 1H and 13C NMR spectral data for three new triterpenoid saponins from Ilex hainanensis Merr.Magnetic Resonance in Chemistry, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Triterpenoids from the Leaves ofIlex hainanensisHelvetica Chimica Acta, 2007
- Herb-drug interactionsThe Lancet, 2000
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986